FME — Fresenius Medical Care AG Cashflow Statement
0.000.00%
Last trade - 00:00
- €10.74bn
- €22.35bn
- €19.45bn
- 84
- 78
- 24
- 69
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1,439 | 1,436 | 1,219 | 894 | 732 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 305 | 215 | 232 | 127 | 202 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -834 | 685 | -653 | -650 | 64.8 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 2,567 | 4,233 | 2,489 | 2,167 | 2,629 |
Capital Expenditures | -1,163 | -1,085 | -887 | -770 | -711 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -2,123 | -250 | -310 | 35.6 | 167 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -3,286 | -1,335 | -1,196 | -735 | -544 |
Financing Cash Flow Items | 153 | -694 | -280 | -124 | -340 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -467 | -2,664 | -1,024 | -1,617 | -1,859 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1,138 | 73.8 | 400 | -208 | 153 |